Neupogen (Amgen Inc.) en es it fr

Neupogen (Amgen Inc.) Brand names, Neupogen (Amgen Inc.) Analogs

Neupogen (Amgen Inc.) Brand Names Mixture

  • Myoflex (Paracetamol + Chlormezanone)

Neupogen (Amgen Inc.) Chemical_Formula

C845H1343N223O243S9

Neupogen (Amgen Inc.) RX_link

http://www.rxlist.com/cgi/generic/filgrastim.htm

Neupogen (Amgen Inc.) fda sheet

Neupogen (Amgen Inc.) msds (material safety sheet)

Neupogen (Amgen Inc.) Synthesis Reference

No information avaliable

Neupogen (Amgen Inc.) Molecular Weight

18802.8

Neupogen (Amgen Inc.) Melting Point

60 oC (Luo, P., Protein Science 11:1218-1226 (2002))

Neupogen (Amgen Inc.) H2O Solubility

No information avaliable

Neupogen (Amgen Inc.) State

Liquid

Neupogen (Amgen Inc.) LogP

0.209

Neupogen (Amgen Inc.) Dosage Forms

Solution

Neupogen (Amgen Inc.) Indication

Increases leukocyte production, for treatment in non-myeloid cancer,neutropenia and bone marrow transplant

Neupogen (Amgen Inc.) Pharmacology

Used in the treatment of chemotherapy-induced neutropenia by enhancing the production of neutrophils. Filgrastim acts on hematopoietic cells by binding to specific cell surface receptors thereby stimulating proliferation, differentiation, commitment, and end cell functional activation.

Neupogen (Amgen Inc.) Absorption

No information avaliable

Neupogen (Amgen Inc.) side effects and Toxicity

No information avaliable

Neupogen (Amgen Inc.) Patient Information

BIOD00072.html

Neupogen (Amgen Inc.) Organisms Affected

No information avaliable